# The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )

> **NCT03059979** · EARLY_PHASE1 · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Systemic Sclerosis
- Raynaud Phenomena

## Interventions

- **DRUG:** Methylprednisolone
- **OTHER:** sodium chloride

## Key facts

- **NCT ID:** NCT03059979
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2021-07-01
- **Final completion:** 2021-07-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2019-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059979, "The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc )". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03059979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*